Work

A novel oral microtubule inhibitor utidelone capsule (UTD2): A phase 1 clinical study to assess the tolerability, safety, and efficacy in advanced solid tumors.

Year: 2024

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2024.42.16_suppl.e15014

Authors: Judy S. Wang, Brian Andrew Van Tine, Manish R. Patel, Diana L. Hanna, Li Tang, Rongguo Qiu, Jin Guan, Jacob Stephen Thomas

Institutions: Washington University in St. Louis, University of Southern California, USC Norris Comprehensive Cancer Center, Biostar (United States)

Language: English

Topic: Cancer Treatment and Pharmacology

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4399325693

Cites:

Cited by:

Related to: 10